Cargando…
How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014
BACKGROUND: Malaysia’s public healthcare sector provides a greater volume of medicines at lower overall cost compared to the private sector, indicating its importance in providing access to medicines for Malaysians. However, the Ministry of Health (MOH) has concerns about the continuous increase in...
Autores principales: | Hamzah, NM, Perera, P. N., Rannan-Eliya, R. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275478/ https://www.ncbi.nlm.nih.gov/pubmed/32503539 http://dx.doi.org/10.1186/s12913-020-05362-8 |
Ejemplares similares
-
Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018) -
Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019) -
Medicines Prices and Malaysia—Untangling the Medicines Web
por: Hill, Suzanne
Publicado: (2007) -
The prices outpatients have to pay for purchasing medicines in Armenia
por: Kazaryan, Irina, et al.
Publicado: (2015) -
Medicine and Money
Publicado: (1888)